HOME >> BIOLOGY >> NEWS
UCLA's California NanoSystems Institute partners with Abraxis BioScience

The California NanoSystems Institute (CNSI) at UCLA today announced a partnership with the integrated global biopharmaceutical company Abraxis BioScience Inc. to collaborate on nanobiotechnology research for the advancement of new technologies in medicine.

Abraxis BioScience will collaborate with the institute and its team of leading researchers to capitalize on the recent explosion in nanoscience and to chart the future of nanotechnology within biotechnology. Abraxis has agreed to contribute $10 million over 10 years to fund collaborative projects at UCLAs new CNSI building. The Abraxis/CNSI Research Collaboration Lab will focus on translational science, quickly translating scientific discoveries into practical applications.

Abraxis BioScience has joined the CNSI Partners Program and is the institutes first partner in the area of pharmaceuticals and biotechnology. The partnership provides CNSI and Abraxis researchers the opportunity to jointly pursue innovative approaches to the diagnosis and treatment of life threatening diseases, leveraging the complementary resources and skills of both organizations. To further support the partnership, visiting scholars from other institutions will also participate in the collaborative research programs.

We are eager to collaborate with Abraxis BioScience. Cross-disciplinary collaboration is vital to our research efforts, said Fraser Stoddart, CNSI director and UCLAs Fred Kavli Professor of Nanosystems Sciences. The exciting thing about nanosystems research is that it is bringing about a sea change in the academic environment it is breaking down the barriers between disciplines to achieve a seamless integration between chemistry, physics, biology and engineering in all of their different forms.

We are very excited about this research collaboration with the CNSI and believe this type of relationship emphasizes our commitment toward pursuing innovative research and forging new paradigms
'"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
26-Jul-2007


Page: 1 2

Related biology news :

1. News conference on plant diseases and issues important to California
2. Expert to provide update after worst tomato virus hits California
3. Plant diseases and issues that are of importance to Californias economy and agriculture
4. Californians urged to help reduce spread of Sudden Oak Death
5. Salmon tracking program expands to California
6. Regulating Californian stem cell research, and more
7. Brown rot shrivels prune production in California
8. Disease opened door to invading species in California
9. Altered ocean currents disturb ecosystem off Northern California and Oregon coast
10. California scientists find natural way to control spread of destructive Argentine ants
11. University of California, San Diego-led team discovers how we detect sour taste

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft System ... over the next decade to reach approximately $14.21 billion by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):
(Date:5/23/2017)... ... ... Vortex Biosciences , provider of circulating tumor cell (CTC) capture systems, ... Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. The peer ... Dr. Matthew Rettig at the University of California, Los Angeles. The publication describes the ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... machine manufacturers to re-engineer their control technology again and again. METTLER TOLEDO has ... for machine manufacturers. The videos illustrate how integration of the ACT350 into Siemens ...
(Date:5/21/2017)... , ... May 20, 2017 , ... ... helps avoid the lengthy trial and error process by finding the right antidepressant ... can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great ... company continues to grow. CSM has doubled in size over the past six ... aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger ...
Breaking Biology Technology:
Cached News: